mild headache; body aches; This is a spontaneous report from a non-contactable consumer. A 39-year-old female patient (also reported as age at vaccination) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported) on 29Dec2020 (age: 39 years) for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Jan2021, the patient experienced body aches. The patient had a mild headache on 20Jan2021. Unknown if treatment was given in response to the events. The patient was not pregnant at the time of vaccination. The outcome of the events was recovered on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.